Found 11 matching trials
Monthly Versus Daily Buprenorphine Formulations for Treatment of Opiate Use Disorder PHASE4 Opioid use disorder and opioid-related deaths are increasing across Canada....
Show More Location
Royal Victoria Regional Health Centre
Learn More & Join Trial
Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2). PHASE1 The purpose of the study is to assess drug-drug interaction (DDI) and safet...
Show More Learn More & Join Trial
Injectable Buprenorphine in Prison: A Preference Trial PHASE4 The goal of this pilot trial is to compare two branded extended-release bup...
Show More Location
Rhode Island Department of Corrections
Learn More & Join Trial
Sublingual Buprenorphine Through Telemedicine vs In-Person Care as Usual PHASE2 This study will compare in-person induction and maintenance dosing of subli...
Show More Location
Multiple Locations
Learn More & Join Trial
Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and Prevention of Overdose PHASE2 The investigators aim to test the effectiveness of a high maintenance daily...
Show More Learn More & Join Trial
Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy (RDD) PHASE2 This is a two phase study investigating combinations of pharmacological and...
Show More Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences (UAMS) / Center for Addiction Services and Treatment (CAST)
Learn More & Join Trial
Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment PHASE4 This study seeks to improve the treatment of chronic pain in people who are...
Show More Status
Active Not Recruiting
Location
Alcohol and Drug Abuse Program (ADAP) - UM Addiction Treatment Center
Learn More & Join Trial
Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder PHASE2 Opioid Use Disorders (OUD) cause significant burden to individuals, familie...
Show More Location
Clinics of Dr. Edwin Chapman @ MHDG
Learn More & Join Trial
Evaluating Buprenorphine/Naloxone Microdosing vs. Standard Dosing in Emergency Departments PHASE2 This is a multi-centre, open-label RCT at four Emergency Departments (EDs) ...
Show More Location
Foothills Medical Centre
Learn More & Join Trial
Comparing Rapid Micro-Induction and Standard Induction of Buprenorphine/Naloxone for Treatment of Opioid Use Disorder PHASE2 The current first-line treatment for opioid use disorder (OUD) in Canada is...
Show More Location
Vancouver General Hospital
Learn More & Join Trial